Corporate Action 2018

Issue link: https://raconteur.uberflip.com/i/998795

Contents of this Issue


Page 1 of 11

02 CORPORATE ACTION /corporate-action-2018 W hen it comes to rais- ing money for can- cer, there isn't much people will not do: run marathons, bake cakes, shave their hair. Mental health, once the Cinderella of charitable causes, can these days call on royalty. People scared of heights will jump from planes or abseil down the tallest buildings if they believe it will end cruelty to dogs or cats. How far would you run for obstet - ric fistula? Would family and friends support you if you held a pub quiz to raise money to pay for treatment? The chances are you would have to begin by explain- ing what fistula is and that is no easy task. It takes courage and deep commit- ment for an organisation to embark on a charitable initiative to support the treatment and care of women in Kenya affected by obstetric fistula. Yet this is what Astellas Pharma Europe, the pharmaceuticals com- pany, did in 2014 with an ambitious programme to help thousands of women rebuild their lives. Obstetric fistula most commonly occurs among women who live in the poorest countries, who give birth without access to medical help, suffering excruciating pain for days before the baby is finally dis - lodged. The baby rarely survives. A n obstetric f istula is a hole between the vagina and rectum or bladder that is caused by pro- longed obstr ucted labour, leaving a woman incontinent. The labour produces contractions that push the baby's head against the moth- er's pelvic bone. The sof t tissues between the baby's head and the pelvic bone are compressed and do not receive adequate blood f low. The lack of blood f low causes this delicate tissue to die and, where it dies, holes are created between the bladder and vagina or The fight against fistula CORPORATE ACTION @raconteur /raconteur.net @raconteur_london 30k 3k backlog of cases estimated before the Astellas programme got underway 1 in 50 For ever y one woman that gets treatment, at least 50 go without women in Kenya develop obstetric fistula each year With so many worthy causes looking for support, why has a pharmaceutical company chosen to focus on a distressing condition that many have never heard of? CHARLES ORTON-JONES Award-winning journalist, he was editor-at-large of LondonlovesBusiness. com and editor of EuroBusiness. MARTIN BARROW Former health editor, news editor, foreign news editor and business news editor at The Times, he specialises in the NHS and social care. SIMON BROOKE Award-winning freelance journalist, who writes for a number of international publications, he specialises in lifestyle trends, health, business and marketing. Distributed in MARTIN BARROW Funded by Astellas Pharma Europe CONTRIBUTORS OVERVIEW Publishing manager Richard Hadler Digital content executive Francesca Cassidy Head of production Justyna O'Connell Design Grant Chapman Kellie Jerrard Samuele Motta Head of design Tim Whitlock Production editor Benjamin Chiou Managing editor Peter Archer Although this publication is funded through advertising and sponsorship, all editorial is without bias and sponsored features are clearly labelled. For an upcoming schedule, partnership inquiries or feedback, please call +44 (0)20 3877 3800 or email info@raconteur.net Raconteur is a leading publisher of special-interest content and research. Its publications and articles cover a wide range of topics, including business, finance, sustainability, healthcare, lifestyle and technology. Raconteur special reports are published exclusively in The Times and The Sunday Times as well as online at raconteur.net The information contained in this publication has been obtained from sources the Proprietors believe to be correct. However, no legal liability can be accepted for any errors. No part of this publication may be reproduced without the prior consent of the Publisher. © Raconteur Media raconteur.net Obstetric fistulas most commonly occur among women who live in the poorest countries, who give birth without access to medical help 4.5k women in Kenya are targeted to get access to fistula treatment by 2020, under the Action On Fistula programme

Articles in this issue

Links on this page

Archives of this issue

view archives of Raconteur - Corporate Action 2018